A probable linking sequence between two transmembrane components of bacteriorhodopsin  by Katre, Nandini V. & Stroud, Robert M.
Volume 136, number 1 FEBS LETTERS December 1981 
A PROBABLE L INKING SEQUENCE BETWEEN TWO TRANSMEMBRANE COMPONENTS 
OF BACTERIORHODOPSIN 
Nandini V. KATRE and Robert M. STROUD 
Department ofBiochemistry and Biophysics, University of California, School of Medicine, San Francisco, 94143, USA 
Received 19 October 1981 
1. Introduction 
Purple membrane from Halobacterium halobium 
contains predominantly one protein, bacteriorhodop- 
sin, which acts as a light.driven proton pump [1], and 
which consists of 7 transmembrane rods of electron 
scattering density [2]. X-Ray diffraction analysis 
[3,4] suggests hat he rods correspond predominantly 
to a-helical regions, oriented roughly perpendicular to
the membrane plane. However, which parts of the 
sequence are contained in the rods within the bilayer 
and which correspond to the linking regions between 
helices is not known. Enzymatic leavage [5,6] or 
chemical modification of the protein, using reagents 
which preferentially position either into the aqueous, 
or the lipid phase identify linking or transmembrane 
regions. 
We describe specific labelling oftyrosines accessible 
to lactoperoxidase iodination of bacteriorhodopsin 
from the aqueous phase. The site of modification is 
located by separation of peptides using Sephadex 
LH-60 chromatography and amino acid analysis. 
2. Methods 
2.1. Isolation of  purple membrane 
Halobacterium halobium strain RI was grown and 
purple membrane was isolated as in [7]. 
2.2. Iodination of  tyrosines in purple membrane 
The tyrosine residues of bacteriorhodopsin were 
modified using sodium [12sI]iodide and the lactoper- 
oxidase-glucose oxidase nzyme system [8] immobi- 
lized on hydrophilic polyacrylamide b ads (Enzymo- 
beads), obtained from BioRad. Purple membrane (2
mg) was suspended in 1 ml 0.2 M phosphate buffer 
(pH 7.2). The Enzymobead reagent (1 mg) dissolved 
in 0.5 ml distilled water was added to the membrane 
suspension. A 10-fold excess of NalZSI over purple 
membrane was then added and the reaction started 
by addition of 0.25 ml 2% glucose. After 15 min at 
room temperature, the enzymobeads were removed 
by centrifugation 1000 × g for 5 min. The purple 
membrane was washed several times with phosphate 
buffer, and concentration assayed using extinction 
coefficient esT0 = 63 × 10 a cm -1 for the light-adapted 
form [9]. The same procedure was used to iodinate 
20 mg protein, using non-radioactive Nal. 
2.3. Identtfication of  labeled residues 
The radioactive and non-radioactive iodinated 
samples were mixed and initial cleavage of labeled 
protein was performed by treatment of apomembrane 
with a-chymotrypsin (Sigma Chemical Co.) at a ratio 
of 1.5 X 10 -2 mg/mg protein, for 5 h, as described 
[5 ]. Apomembrane was generated by bleaching in 1 M 
hydroxylamine hydrochloride, pH 7.0 at 37°C for 
2-3 hours [10], and collected by centrifugation at 
25 000 × g. The two chymotryptic fragments gener- 
ated were separated by Sephadex LH-60 chromatog- 
raphy (column size 2.0 cm diam. × 60 cm length), 
using 96% formic acid and ethanol (2.5:7) as elution 
buffer and 2 ml fractions were collected. The larger 
of the 2 chains (residues 72-248), named (CTI) and 
the smaller chain (CTII residues 1-71) were separated. 
CTI was lyophilized, dissolved in 70% HCOOH and 
treated with cyanogen bromide (CNBr) in 70% 
HCOOH. A 100-fold molar excess of CNBr over 
methionine r sidues was used. The reaction mixture 
was incubated at 37°C for 24 h, after which it was 
diluted 10-times with distilled water and lyophilized. 
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The lyophilized CNBr fragments of  CTI were separated 
on Sephadex LH-60 as above. 
The peak containing radioactivity was lyophilized 
and subjected to amino acid analysis and polyacryl- 
amide (15%)-SDS gel electrophoresis [11]. 
Amino acid analysis was carried out on a Beckman 
121 M amino acid analyzer following complete acid 
hydrolysis in 12 N HCI for 22 h. Radioactivity was 
counted on a Beckman model 300 gamma-counter. 
3. Results 
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Chymotryptic cleavage of bacteriorhodopsin gave 
2 fragments migrating with app. M r 19 000 (CTI) and 
7000 (CTII) on SDS-polyacrylamide g ls. Separation 
of these 2 fragments on Sephadex LH-60 is shown in 
fig.1. The difference in absorbance at 280 nm for the 
2 fractions was primarily due to the different numbers 
of tryptophan and tyrosine residues in the sequences 
(6 Trp, 7 Tyr in CTI; 2 Trp, 4 Tyr in CTII). 0.2 + 
0.04 mol 12sI was bound/mol purple membrane. 
12sI was associated mainly with the CTI fragment. 
The separation of the CNBr fragments of labeled CTI 
gave primarily one radioactive peptide (fig.2). The 
radioactivity with the void volume was due to aggre- 
gated material. 
CNBr cleavage of CTI results in 5 fragments. Start- 
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Fig.1. Fractionation of iodinated purple membrane after 
cleavage, on Sephadex LH-60: ( - - - )  absorbance at280 nm 
of the fractions; ( - - )  cpm of the iodinated purple mem- 
brane; CTI contained residues 72-248; CTII contained resi- 
dues 1-71. 
< 
Fig.2. Fractionation ofCTI (the larger chymotryptic frag- 
ment) of iodinated bacteriorbodopsin after CNBr cleavage, 
on Sephadex LH-60: ( - - )  represents absorbance of frac- 
tions at 280 nm; ( - - - )  represents epm of the iodinated pep- 
tide. 
ing from the N-terminus, I has residues 72-118,  II 
(119-145),  III (146-163) IV (164-209) and V (210 ,  
248). V contains no tyrosine or tryptophan, hence no 
absorbance at 280 nm. The amino acid analysis of  the 
main radioactive peptide, containing the modified 
tyrosine(s) is shown in table 1. This peptide best 
Table 1 
Amino acid analysis: CNBr fragment containing modified 
tyrosine 
Found Expected for the 5 CNBr fragments of 
CTI 
! II III IV V 
Lys 1.1 0 1 1 1 1 
Arg 0.8 1 1 0 2 2 
Asp 0.8 5 0 0 2 2 
Thr 2.8 3 3 1 3 1 
Ser 1.6 0 2 2 3 4 
Glu 0.6 3 0 1 3 3 
Pro 0.7 2 0 0 3 2 
Gly 2.3 5 3 1 3 5 
Ala 4.0 6 4 1 3 8 
Val 2.4 2 3 1 8 3 
lie 1.8 3 2 1 3 2 
Leu 2.8 10 2 3 7 4 
Tyr 1.5 a 2 2 2 1 0 
Phe 1.5 1 1 0 2 2 
RMS deviation +2.8 +0.5 +1.3 +2.4 +1.9 
a Tyr was not used to calculate X2 
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Volume 136, number 1 FEBS LETTERS Dec, ember 1981 
~+ 
I 
I 
Oi 
I 
I hi, 0,, ~ ~' . i  ,,.i I [  
i 
• • . i l  
- ~  . ~ ~. 0 = I  
~'. "~.  ~" ~_ ~_ ~ I 
~ i ~  I ~ ~ i ~ s ~  I 
. j  
o~ .~ ~. t ! 
I 
l 
! 
! 
I 
h .  - - -~  = 
! 
- i  
Q 
Q m 
I .  
X 
ILl 
172 
Volume 136, number 1 FEBS LETTERS December 1981 
matched the CNBr peptide II (amino acids 119-145), 
which contains tyrosines 131 and 133. 
The iodination reaction did not result in any shift 
in Xma x at 570 nm of the light-adapted modified 
purple membrane, indicating no major structural 
changes involving the retinyl moiety. 
4. Discussion 
The conditions we utilized for iodination of tyro- 
sines were optimized to label the residues most acces- 
sible from the aqueous phase, which can constitute 
the linking regions between the transmembrane com- 
ponents of bacteriorhodopsin. The tyrosines involved 
in the transmembrane rod-like structures, buried in 
the hydrophobic region of the membrane are not likely 
to be modified. The stoichiometry of labeling was 
low, 0.2 + 0.04 mol nSI/mol protein under these con- 
ditions. The labeling pattern indicates that the modi- 
fied tyrosine(s) are contained in the peptide, amino 
acids 119-145. Therefore one or both of the only 
tyrosines 131 and 133 are likely to be in the linking 
region. 
The scheme shown in fig.3 shows an arrangement 
of the amino acid sequence organized into 7 trans- 
membrane stretches and arranged in an a-helical 
pattern. Slightly different arrangements have been 
published in [6,12]. 
Experimental evidence, mainly enzymatic leavage 
using a-chymotrypsin, papain and trypsin, has deter. 
mined the amino acid residues which constitute the 
N-terminus, the C-terminus tail and the linking region 
between helix B and helix C [5,6,13]. The iodination 
of tyrosines 131 and/or 133, establishes the likely 
linking region between helix D and helix E. There are 
3.4 residues/a.helical turn, thus ~27 residues con- 
tained in 8 turns would be sufficient o just span the 
distance between lipid head groups across the bilayer 
[14,15 ]. Using this, the remaining amino acid residues 
have been arranged in the scheme shown in fig.3. 
There is some minor radioactivity associated with 
CTII, shown in fig.1. This may be modification of 
tyrosine 64 which is close to the external surface of 
the protein. Longer reaction times leads to labeling 
of both CTI and CTII. This is likely to be due to the 
modification of less accessible tyrosines, and tyrosines 
in the membrane r gion. Earlier modifications of 
tyrosines in purple membrane showed 1-2 tyrosines 
modified by free iodine [ 16], or more (up to 8 -9  total 
[17]) or (up to 4 [18]) by tetranitromethane. In the 
latter cases, the reagents may be sufficiently hydro- 
phobic to enter the lipid phase. 
These data help establish the linking sequence of 
amino acids between helices D and E, that is between 
the helices 4 and 5, from the N-terminus. 
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